Glycycoumarin

Glycycoumarin is a bioactive coumarin compound isolated primarily from licorice root (Glycyrrhiza uralensis) that exerts anti-inflammatory effects by potently suppressing inducible nitric oxide synthase (iNOS) activity. It also demonstrates hepatoprotective, antibacterial, and antiviral properties in preclinical models, making it a compound of interest in liver health and infectious disease research.

Origin & History

Glycycoumarin is a coumarin compound primarily extracted from the roots and rhizomes of Glycyrrhiza uralensis Fisch., a species of licorice. It is isolated using a series of chromatographic techniques and confirmed through spectrometry and NMR analysis.

Historical & Cultural Context

Glycycoumarin is found in licorice plants, traditionally used in Chinese medicine. However, there are no specific historical uses attributed to this isolated compound.

Health Benefits

• Exhibits anti-inflammatory properties by inhibiting NO production by over 80% at concentrations of 10 µmol/L, noted in preclinical studies. • Demonstrates liver protection effects in animal models, although specific studies are not cited. • Shows antibacterial and antiviral activities, including binding affinity to SARS-CoV-2 3CLpro, indicated by in vitro studies. • Acts as an antioxidant, supported by in vitro research. • Displays anti-hepatitis C virus activity in preclinical evaluations.

How It Works

Glycycoumarin suppresses inflammation primarily by inhibiting inducible nitric oxide synthase (iNOS), reducing nitric oxide (NO) production by over 80% at concentrations of 10 µmol/L in macrophage models. It is also believed to downregulate pro-inflammatory transcription factors such as NF-κB, reducing downstream cytokine signaling cascades. Its hepatoprotective activity may involve modulation of oxidative stress pathways, including upregulation of antioxidant enzyme expression such as superoxide dismutase (SOD) and catalase.

Scientific Research

No human clinical trials, RCTs, or meta-analyses have been identified for glycycoumarin. Current evidence is limited to preclinical studies involving in vitro and animal models.

Clinical Summary

The majority of evidence supporting glycycoumarin's effects comes from in vitro cell studies and in vivo animal models, with no substantial randomized controlled human clinical trials published to date. Anti-inflammatory activity has been quantified in macrophage cell line studies, where NO inhibition exceeded 80% at 10 µmol/L, a potent and specific finding. Hepatoprotective effects have been observed in rodent models of liver injury, though the specific study parameters and sample sizes remain incompletely documented in available literature. The overall evidence base is preclinical and promising but insufficient to establish clinical dosing guidelines or confirmed therapeutic efficacy in humans.

Nutritional Profile

Glycycoumarin is a prenylated coumarin compound (molecular formula C20H18O5, molecular weight ~338.35 g/mol) isolated primarily from Glycyrrhiza uralensis (licorice root). It is classified as a bioactive secondary metabolite rather than a conventional nutritional ingredient, and thus lacks macronutrient or micronutrient content of its own. Key structural features include a coumarin core with a prenyl side chain and methoxy substitution, contributing to its lipophilic character and moderate bioavailability. As a pure compound, it contains no protein, fat, carbohydrates, fiber, vitamins, or minerals. Bioactive concentration data: anti-inflammatory activity (NO inhibition >80%) observed at 10 µmol/L in RAW 264.7 macrophage cell models; antibacterial and antiviral activity, including SARS-CoV-2 3CLpro binding, documented in in vitro assays at low micromolar ranges (estimated IC50 values in the 5–20 µmol/L range based on related prenylcoumarins). Antioxidant capacity has been reported in DPPH and ABTS radical scavenging assays, with activity generally comparable to other licorice-derived flavonoids. Bioavailability is limited by its hydrophobic nature; oral absorption is estimated to be low without formulation enhancement, though the prenyl group may improve membrane permeability relative to non-prenylated coumarins. No established dietary reference intake or therapeutic dosing range is currently defined in clinical literature.

Preparation & Dosage

There are no clinically studied dosage ranges reported for glycycoumarin. Preclinical studies have used concentrations up to 10 µmol/L for anti-inflammatory effects in vitro. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Licorice root extract, Vitamin C, Quercetin, Resveratrol, Curcumin

Safety & Interactions

Glycycoumarin, as a coumarin-class compound, carries a theoretical risk of hepatotoxicity at high doses, consistent with concerns raised about synthetic coumarins, though direct toxicity data for glycycoumarin specifically are limited. Coumarins as a class may potentiate the effects of anticoagulant drugs such as warfarin by interfering with vitamin K-dependent clotting factor synthesis, and caution is warranted when combining glycycoumarin-containing supplements with blood thinners. Pregnancy and breastfeeding safety has not been established, and use during these periods should be avoided due to the lack of safety data. Individuals with existing liver conditions or those taking hepatically metabolized drugs should consult a healthcare provider before use.